Harvard's Office of Technology Development and LabCentral invite you to the latest event in the Guppy Tank series, where two teams of Harvard life-science innovators will pitch their concepts to a panel of entrepreneurs and investors for constructive, in-depth feedback.

Please join us on February 16 from 4 to 6 p.m. to learn from experts on startup formation and participate in giving audience feedback. Networking reception to follow.

RSVP here

This "episode" features:

Immune-Prints™ immunotherapy discovery engine
Dave Weitz and Assaf Rotem, Harvard University, and Sol Efroni, Bar Ilan University
The Immune-Prints single cell sequencing platform, combined with a proprietary computational pipeline, enables analysis of patients’ cells to predict response to existing immunotherapies and drive the development of new immune-oncology drugs.

UniverCell - Universal donor stem cells
Chad Cowan, Harvard University
Universal donor stem cells generated at Harvard have the potential to overcome immune rejection and enable repair and replacement of diseased and damaged tissue.

Both teams will be seeking feedback regarding application priorities and commercialization models.